iBET continues its our goal for strategic growth towards future challenges
July 24, 2013
The Analytical Services Unit, a joint department of iBET and ITQB-UNL under the executive management of iBET, has been granted a Manufacturer Authorization from INFARMED that allows it to further extend its scope of activities to quality control and lot release of active pharmaceutical ingredients (APIs), namely human medicinal and
human investigational medicinal products.
The authorization falls under the Art. 40 of Directive 2001/83/EC and Art. 13 of Directive 2001/20/EC, or Good Manufacturing Practices (GMP) and comprises:
- Non-sterile products
- Batch certification
- Biological medicinal products
- Immunological products
- Cell therapy products
- Gene therapy products
- Biotechnology product
- Quality Control Testing
- Microbiological: non-sterility
- Chemical/Physical
- Biological